Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 23 of 498 for:    LENALIDOMIDE AND every 28 days

Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01572480
Recruitment Status : Recruiting
First Posted : April 6, 2012
Last Update Posted : September 6, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 1, 2022
Estimated Study Completion Date : June 1, 2023
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):